Extracorporeal methods of decontamination key points
Key points have been added to the Extracorporeal methods of decontamination page.
Updates
Other methods of GIT decontamination key points
Key points have been added to the Other methods of GIT decontamination page.
Drug induced seizures key points
Key points have been added to the Drug induced seizures page.
Activated charcoal formulations
The Activated charcoal page has been updated with some additional information about activated charcoal formulations.
Activated charcoal key points
Key points have been added to the Activated charcoal page.
Sodium channel blockade links
Links to other relevant pages have been added to and from the Na channel blocking agents page.
Management of poisoning key points
Key points have been added to the Management of poisoning page
Reducing heat generation in heat stroke
A new segment on reducing heat generation on the Heat stroke page has been added.
Heat stroke
The Heat stroke page has been extensively revised and updated.
Hypothermia
The Hypothermia page has been revised and updated.
Assessment of hypothermia
The Assessment of hypothermia page has been extensively revised and updated.
Hypothermia management
The Management of hypothermia page has been extensively revised and updated to better reflect the Australian and New Zealand environment.
Toxidromes key points
Key points have been added to the Toxidromes page.
Poisoning by unknown substances key points
Key points have been added to the Poisoning by unknown substances page.
History in poisoning by unknown substances
A short segment on history has been added to the Poisoning by unknown substances page.
Epidemiology of poisoning key points
Key points have been added to the Epidemiology of poisoning page.
Regional anaesthesia key points
Key points have been added to the Regional anaesthesia page.
Phosphatidylethanol
A short segment on phosphatidylethanol testing has been added to the Ethanol page.
Andexanet for ICH in patients on DOACs
The Management of stroke page has been updated with some information about andexanet for the treatment of ICH in patients taking DOACs – there is insufficient evidence of benefit to recommend it at present. Future trials will need to be better designed than this one. Connolly, S. J., Sharma, M., Cohen, A. T. et al., … Read more
Neurosurgical transfer following trauma
Indications for transfer to a neurosurgical service following trauma have been added to the Management of head trauma page.